Regeneron Pharmaceuticals Inc (MEX:REGN)
MXN 18667 16.7 (0.09%) Market Cap: 2.04 Tn Enterprise Value: 1.90 Tn PE Ratio: 24.59 PB Ratio: 3.63 GF Score: 92/100

Regeneron Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 09, 2020 / 07:00PM GMT
Release Date Price: MXN12504.05
Terence C. Flynn
Goldman Sachs Group Inc., Research Division - MD

Great. Thanks for joining us, everybody. This is Terence Flynn. I cover the biopharma sector at Goldman Sachs. We're very pleased to have Regeneron Pharmaceuticals joining us today at our conference. We have Dr. Izzy Lowy, who is Senior Vice President, Translational Science and Oncology; and Justin Holko, who is Vice President, Investor Relations.

I think, first, Justin had some -- a statement to make, and then we're going to launch into Q&A.

Justin Holko
Regeneron Pharmaceuticals, Inc. - VP of IR

Thanks, Terence, and good afternoon, everybody. We're pleased to be joining you today in this conference. As always, we will be making some forward-looking statements as it pertains to our pipeline and our business. Please refer to our SEC filings as a reference to some of the risks and uncertainties associated with the business. Any of the statements that we make may not come true, but obviously, we'll do our best to deliver on those statements.

Happy to turn it back to you

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot